13
Jul 2026
New study tracks early genetic changes in hepatitis E virus
Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability.
Stay Informed!
13
Jul 2026
Smelling dark chocolate before training may improve workout performance
Chocolate odors influence resistance exercise performance in fasted men, highlighting the potential of sensory cues to enhance training and appetite control.
13
Jul 2026
Global consortium releases AI toolbox to unlock new Alzheimer's treatments
The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN), a global collaboration of academic researchers, pharmaceutical companies, and philanthropic organizations of which Washington University School of Medicine in St. Louis is a founding member, today launched three open-source AI tools to accelerate research aimed at developing new treatments for Alzheimer's disease and other neurodegenerative diseases.
13
Jul 2026
Animal-free lung model unlocks better treatments for RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and its immune response to ensure babies get the best possible outcomes, finds a new study by researchers at UCL and Great Ormond Street Hospital for Children (GOSH).
13
Jul 2026
Engineered ribozyme repairs broken RNA to explain origins of life
In most modern cells, DNA stores the genetic blueprint, and relies on proteins to replicate, repair and build from those blueprints.
13
Jul 2026
Social media and low body esteem fuel cosmetic procedure addiction
As cosmetic procedures become increasingly normalized worldwide, new research suggests that for some women, repeated treatments may become addiction-like rather than purely cosmetic.
13
Jul 2026
Nearly one in 10 Britons use or want weight-loss medication
The prevalence of GLP-1 receptor agonists for weight management in Great Britain highlights public interest and concerns over safety and prescribing practices.
13
Jul 2026
Tescan joins Shimadzu Group to accelerate innovation and deliver greater value to customers
Tescan, a pioneer in electron microscopy, announces the successful completion of its full acquisition by Shimadzu Corporation.
13
Jul 2026
Study links GLP-1 treatment to fewer alcohol drinking days
Current GLP-1 receptor agonist prescriptions were associated with modestly lower AUDIT-C scores in a large, diverse US cohort. The difference appeared to reflect less frequent drinking rather than fewer drinks per occasion or fewer binge-drinking episodes.
12
Jul 2026
Gut microbiota may shape eating behavior and guide new obesity treatments
The review shows how gut microbiota may influence appetite, food reward, inflammation, and energy balance through the gut-brain axis. Microbiota-targeted approaches could support future treatments for obesity and eating disorders, but clinical evidence remains limited.
